Disorder of purine metabolism

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:79191
Who is this for?
Show terms as
1Active trials35Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Disorders of purine metabolism are a group of rare inherited conditions where the body cannot properly break down or recycle purines — natural chemical building blocks found in every cell. Purines are essential for making DNA, RNA, and energy molecules like ATP. When the enzymes that handle purines do not work correctly, harmful substances can build up, or important molecules can become too scarce. This disrupts many body systems depending on which enzyme is affected. There are several distinct conditions within this group, including adenosine deaminase deficiency (ADA deficiency), purine nucleoside phosphorylase deficiency (PNP deficiency), adenylosuccinate lyase deficiency, ADSL deficiency, xanthinuria, and Lesch-Nyhan syndrome, among others. Symptoms vary widely by subtype but can include problems with the immune system, neurological development, kidney stones, joint pain, and intellectual disability. Some forms cause severe combined immunodeficiency (SCID), leaving children extremely vulnerable to infections from birth. Treatment depends on the specific subtype. Some forms can be managed with enzyme replacement therapy, dietary changes, or medications to reduce uric acid. Bone marrow or stem cell transplantation can be curative for immune-related forms. Gene therapy has been approved for ADA-SCID in some countries. Early diagnosis is critical because timely treatment can dramatically improve outcomes and quality of life.

Key symptoms:

Frequent or severe infections in early childhoodIntellectual disability or developmental delaysKidney stones or crystals in the urineJoint pain and swelling (gout-like symptoms)Muscle stiffness or involuntary movementsSelf-injurious behavior (in Lesch-Nyhan syndrome)SeizuresFailure to thrive or poor growth in infantsAnemia or low blood cell countsAutism-like behaviors or social difficultiesNeurological regression (loss of previously gained skills)Elevated uric acid levels in blood or urine

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Apr 2026Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia

BioRay Pharmaceutical Co., Ltd. — PHASE2

TrialNOT YET RECRUITING
Apr 2026The Remote Monitoring of Gout Feasibility Study in Primary Care

Diakonhjemmet Hospital — NA

TrialNOT YET RECRUITING
Mar 2026Tigulixostat (IBI128) vs Febuxostat in Gout

Innovent Biologics Technology Limited (Shanghai R&D Center) — PHASE3

TrialRECRUITING
Mar 2026Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity

Chang Gung University of Science and Technology — NA

TrialENROLLING BY INVITATION
Feb 2026Acute Effects of a Urate-lowering Bacterial Therapeutic on Small Intestinal Transcriptomics and Glycomics in Healthy Subjects

Örebro University, Sweden — NA

TrialNOT YET RECRUITING
Jan 2026Drug-Drug Interaction Study of ABP-671 in Gout Patients

Atom Therapeutics Co., Ltd — PHASE1

TrialNOT YET RECRUITING
Jan 2026An Exploratory Clinical Study on the Protective Effect of Cycling on the Ankle Joint in Gout

Zhu Xiaoxia — NA

TrialNOT YET RECRUITING
Dec 2025A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)

Protalix — PHASE2

TrialRECRUITING
Dec 2025Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares

Massachusetts General Hospital — PHASE4

TrialRECRUITING
Dec 2025Orlistat and Weight Management for Uric Acid Control in Obese Gout: A RCT

XueMei Guo — NA

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Disorder of purine metabolism.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →

Specialists

Showing 25 of 35View all specialists →
MS
Mikhail Samsonov
Specialist
PI on 17 active trials
WM
William L Nyhan, MD
Specialist
PI on 1 active trial1 Disorder of purine metabolism publication
TM
Tristan Pascart, MD
Specialist
PI on 3 active trials
HM
Hyder A Jinnah, MD
ATLANTA, GA
Specialist
PI on 1 active trial
WP
William L Nyhan, MD, PhD
Specialist
PI on 2 active trials
HP
Helle Kieler, MD, PhD, Assoc Prof
Specialist
PI on 1 active trial
CM
Charles V Pollack, MD
ROSWELL, GA
Specialist
PI on 2 active trials
RM
Rodrigo Suarez-Otero, MD
Specialist
PI on 1 active trial
RM
Rafael Lanuza-Ramirez, MD
Specialist
PI on 1 active trial
CM
Chris Storgard, MD
SAN DIEGO, CA
Specialist
PI on 4 active trials
PM
Peng Liu, M.D.
COLORADO SPRINGS, CO
Specialist
PI on 1 active trial
YM
Yangang Wang, M.D.
Specialist
PI on 1 active trial
YM
Ying Lu, M.D.
Specialist
PI on 1 active trial
BM
Bin Liu, M.D.
Specialist
PI on 1 active trial
XM
Xiumei Liu, M.D.
Specialist
PI on 1 active trial
SM
Shenren Chen, M.D.
Specialist
PI on 1 active trial
YM
Yongde Peng, M.D.
Specialist
PI on 1 active trial
JM
Jinying Lin, M.D.
NEW YORK, NY
Specialist
PI on 1 active trial
RP
Robert Evans, PharmD
Specialist
PI on 3 active trials
JM
Jianqin Wang, M.D.
Specialist
PI on 1 active trial
HM
Haiwang Ji, M.D.
Specialist
PI on 1 active trial
HM
Hong Liu, M.D.
Specialist
PI on 1 active trial
YM
Yonghong Zhang, M.D.
Specialist
PI on 1 active trial
CM
Christopher Wynne, MBChB, Grad Dip Pharm Med
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Disorder of purine metabolism.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Disorder of purine metabolismForum →

No community posts yet. Be the first to share your experience with Disorder of purine metabolism.

Start the conversation →

Latest news about Disorder of purine metabolism

Disease timeline:

New recruiting trial: Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

A new clinical trial is recruiting patients for Disorder of purine metabolism

New recruiting trial: Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout

A new clinical trial is recruiting patients for Disorder of purine metabolism

New recruiting trial: B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis

A new clinical trial is recruiting patients for Disorder of purine metabolism

New recruiting trial: Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

A new clinical trial is recruiting patients for Disorder of purine metabolism

New recruiting trial: Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

A new clinical trial is recruiting patients for Disorder of purine metabolism

New recruiting trial: Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares

A new clinical trial is recruiting patients for Disorder of purine metabolism

New recruiting trial: Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese Non-Diabetic Patients

A new clinical trial is recruiting patients for Disorder of purine metabolism

New recruiting trial: A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)

A new clinical trial is recruiting patients for Disorder of purine metabolism

New recruiting trial: Tight Control of Gouty Arthritis Compared to Usual Care

A new clinical trial is recruiting patients for Disorder of purine metabolism

New recruiting trial: Metformin in Safety and Efficacy in Gouty Patients

A new clinical trial is recruiting patients for Disorder of purine metabolism

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific type of purine metabolism disorder does my child or I have, and what gene is affected?,What treatment options are available for this specific subtype, and are any clinical trials open to us?,Should other family members be tested, and what is the chance of passing this on to future children?,What dietary changes should we make, and should we see a metabolic dietitian?,What warning signs should prompt us to go to the emergency room?,Is newborn screening available for this condition in our country, and should future pregnancies be tested prenatally?,What specialists should be part of our care team, and how often should we have follow-up appointments?

Common questions about Disorder of purine metabolism

What is Disorder of purine metabolism?

Disorders of purine metabolism are a group of rare inherited conditions where the body cannot properly break down or recycle purines — natural chemical building blocks found in every cell. Purines are essential for making DNA, RNA, and energy molecules like ATP. When the enzymes that handle purines do not work correctly, harmful substances can build up, or important molecules can become too scarce. This disrupts many body systems depending on which enzyme is affected. There are several distinct conditions within this group, including adenosine deaminase deficiency (ADA deficiency), purine nuc

Are there clinical trials for Disorder of purine metabolism?

Yes — 1 recruiting clinical trial is currently listed for Disorder of purine metabolism on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Disorder of purine metabolism?

25 specialists and care centers treating Disorder of purine metabolism are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.